BNP PARIBAS FINANCIAL MARKETS - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 16 filers reported holding PTC THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$2,006,360,000
-0.9%
2,000,0000.0%0.00%0.0%
Q1 2022$2,025,000,000
-2.6%
2,000,0000.0%0.00%0.0%
Q4 2021$2,080,000,000
-28.1%
2,000,000
-22.6%
0.00%
-50.0%
Q1 2020$2,891,555,0002,585,0000.01%
Other shareholders
PTC THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 1,500,000$1,161,0000.55%
OAKTREE CAPITAL MANAGEMENT LP 9,700,000$7,617,0000.12%
LAZARD ASSET MANAGEMENT LLC 10,500,000$8,281,0000.02%
Citadel Advisors 17,350,000$13,603,0000.01%
UBS ASSET MANAGEMENT AMERICAS LLC 15,800,000$12,250,372,0000.01%
AMERIPRISE FINANCIAL INC 15,900,000$12,303,0000.01%
CREDIT SUISSE AG/ 4,005,000$3,099,0000.00%
DEUTSCHE BANK AG\ 485,000$375,0000.00%
View complete list of PTC THERAPEUTICS INC shareholders